Literature DB >> 10765088

Where are the limits of elective nephron- sparing surgery in renal cell carcinoma?

A Schlichter1, H Wunderlich, K Junker, H Kosmehl, D H Zermann, J Schubert.   

Abstract

OBJECTIVES: The indication for elective nephron-sparing surgery (NSS) in renal cell carcinoma (RCC) is still controversial. The presented study was performed to determine limitations for NSS regarding to multifocality and to characterize the biological importance of these small tumor lesions.
METHODS: In 372 patients who underwent radical nephrectomy for RCC consecutively, nephrectomy specimens were investigated by using 3-mm parenchyma sections regarding to local tumor spread and multifocality. To characterize multifocal tumors, we performed cytogenetic and molecular genetic investigations.
RESULTS: Serial sections of 372 nephrectomy specimens revealed a total of 92 multifocal tumors in 61 specimens (16.4%). The correlation between tumor size and multifocality is shown as follows: tumor diameter 1-20 mm: 12.5%; 21-30 mm: 23.4%; 31-40 mm: 10.2%; >40 mm: 16.7%. The mean diameter of the multifocal tumors was 8.8x9.1x6.1 mm and the mean distance to the primary tumor was 26.4 mm (5-84 mm). Using cytogenetic and molecular genetic analysis, in nearly one third of all cases a concordance of chromosomal aberrations in primary and secondary tumors was found.
CONCLUSIONS: Multifocality of renal cell carcinoma occurs independently from primary tumor size. The evidence of structural and/or numeric aberrations, found in additional tumor foci, obviously is an argument for their malignant potential. This findings have to be considered in preparation of nephron-sparing surgery for patients with renal cell carcinoma.

Entities:  

Mesh:

Year:  2000        PMID: 10765088     DOI: 10.1159/000020187

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  6 in total

Review 1.  Should there be a size limit for elective nephron-sparing surgery?

Authors:  Kent G Krejci; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

2.  De novo papillary carcinoma in a renal allograft: the pros and cons of immunosuppression.

Authors:  Rachelle Asciak; Jesmar Buttigieg; Louis Buhagiar
Journal:  CEN Case Rep       Date:  2015-11-02

Review 3.  [Recurrent disease in renal cell carcinoma. "Local recurrence" after kidney-sparing and radical resection].

Authors:  M Löhr; D Rohde
Journal:  Urologe A       Date:  2005-04       Impact factor: 0.639

Review 4.  Oncological outcomes of partial nephrectomy for tumours larger than 4 cm: A systematic review.

Authors:  Tarek H El-Ghazaly; Ross J Mason; Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

5.  Role of open nephron sparing surgery in the era of minimal invasive surgery.

Authors:  Gaurav Gupta; Sameer Grover; Santosh Kumar; Nitin S Kekre
Journal:  Indian J Urol       Date:  2009 Oct-Dec

6.  Open partial nephrectomy in renal cancer: a feasible gold standard technique in all hospitals.

Authors:  J M Cozar; M Tallada
Journal:  Adv Urol       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.